Novozymes A/S (OTCMKTS:NVZMF – Get Free Report) is anticipated to release its results before the market opens on Thursday, November 5th. Analysts expect Novozymes A/S to post earnings of $0.7480 per share and revenue of $1.29 billion for the quarter.
Novozymes A/S Stock Performance
OTCMKTS:NVZMF opened at $68.71 on Wednesday. Novozymes A/S has a 52 week low of $52.10 and a 52 week high of $73.07. The stock’s fifty day moving average is $67.32 and its two-hundred day moving average is $62.16.
About Novozymes A/S
Novozymes A/S was a Denmark-based biotechnology company specializing in enzymes and microorganisms for industrial, agricultural, and consumer applications. Its technologies were designed to help customers improve production efficiency, reduce resource use, and develop more sustainable products and processes.
The company developed and marketed enzyme and microbial solutions for industries including food and beverages, household care, agriculture, bioenergy, animal health, and industrial manufacturing.
Read More
- Five stocks we like better than Novozymes A/S
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
